1-3 of 3
Prashant Trikha
Close
Sort by
Journal Articles

Romidepsin in Conditioning and Maintenance Mitigates Relapse Risk and Enhances NK-Cell Cytotoxicity in Patients Receiving Allogeneic Stem Cell Transplant for Aggressive T-Cell Malignancies: Results of a Phase I/II Clinical Trial

Chitra Hosing, Zachary Braunstein, Alaa M Ali, Benigno C. Valdez, Borje S. Andersson, Uday R. Popat, Sumithira Vasu, Karilyn Larkin, Sam Penza, Hannah Choe, Ayman Saad, Marcos J.G. de Lima, Lai Wei, Eric McLaughlin, Robin Nakkula, Amanda Campbell, Prashant Trikha, Marcin Puto, Basem M. William, Richard E. Champlin, Dean Anthony Lee, Jonathan E Brammer
Journal: Blood
Blood (2021) 138 (Supplement 1): 553.
https://doi.org/10.1182/blood-2021-152833
Published: 2021
Journal Articles

A Multi-Omics Approach for Evaluating the Impact of Cytokines and Donor Source on NK Cell Expansion

Sarah Schlotter, Evelyn Navarro, Marcelo de Souza Fernandes Pereira, Aarohi Thakkar, Prashant Trikha, Dean Anthony Lee
Journal: Blood
Blood (2021) 138 (Supplement 1): 1769.
https://doi.org/10.1182/blood-2021-153853
Published: 2021
Journal Articles

Disruption of SOCS3 Promotes the Anti-Cancer Efficacy of Primary NK Cells

Meisam Naeimi Kararoudi, PhD DVM, Ezgi Elmas, MS, Margaret Lamb, MD, Nitin Chakravarti, PhD, Prashant Trikha, PhD, Dean Anthony Lee, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5687.
https://doi.org/10.1182/blood-2018-99-116621
Published: 2018